Bristol-Myers CEO Giovanni Caforio Nets $18.7M in 2017 Pay, a 10% Raise - Pharma News -BoardProspects

Bristol-Myers CEO Giovanni Caforio Nets $18.7M in 2017 Pay, a 10% Raise

Pharma News Mar 28 2018 BoardNews

As Bristol-Myers Squibb presses ahead in oncology and after a big finish in the fourth quarter, CEO Giovanni Caforio is taking home a 10% pay raise for 2017 to $18.7 million. His stepped-up compensation followed a year in which Bristol-Myers exceeded the CEO's overall revenue target—and beat individual sales targets for a list of key drugs...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Actavis Chairman Joins Zoetis Board Under Deal With Activist Investor Ackman also published in Pharma News
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- AstraZeneca Investors Press Exec-Comp Chair to Tie Pay to Pfizer Bid also published in Pharma News
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- A Changed and Changing Executive Compensation Environment also mentions Executive Compensation
- The Other Duty of Corporate Governance also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- AstraZeneca Director Pushing to Tie Exec Pay to Big Growth Promises also published in Pharma News
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned